Adherence to Antihypertensive Therapy

Medical Clinics of North America

Volumn 101, Issue 1, 2017, Pages 229-245

  Peacock, Erin ^a   Krousel Wood, Marie ^a,b,c  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY   (United States)

^c OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Hypertension; Interventions; Medication adherence

Indexed keywords

ANTIHYPERTENSIVE AGENT; DRUG COMBINATION;

BLOOD PRESSURE REGULATION; DISEASE CONTROL; ETHNIC DIFFERENCE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH PROMOTION; HUMAN; HYPERTENSION; INFORMATION PROCESSING; MEDICATION COMPLIANCE; PATIENT EDUCATION; PHARMACEUTICAL CARE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROGRAM EFFECTIVENESS; REVIEW; SEX DIFFERENCE; TELEMONITORING; TREATMENT PLANNING; ATTITUDE TO HEALTH; BLOOD PRESSURE; DRUG COMBINATION; E-MAIL; ECONOMICS; PATHOPHYSIOLOGY; REMINDER SYSTEM; SOCIAL SUPPORT; TEXT MESSAGING;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DRUG COMBINATIONS; ELECTRONIC MAIL; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; MEDICATION ADHERENCE; PATIENT EDUCATION AS TOPIC; REMINDER SYSTEMS; SOCIAL SUPPORT; TEXT MESSAGING;

EID: 84996635731     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2016.08.005     Document Type: Review

References (90)

1. 1 Haynes, R.B., McDonald, H.P., Garg, A.X., Helping patients follow prescribed treatment: clinical applications. JAMA 288:22 (2002), 2880–2883.
2. 2 Kronish, I.M., Ye, S., Adherence to cardiovascular medications: lessons learned and future directions. Prog Cardiovasc Dis 55:6 (2013), 590–600.
3. 3 DiMatteo, M.R., Giordani, P.J., Lepper, H.S., et al. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 40:9 (2002), 794–811.
4. 4 Ho, P.M., Bryson, C.L., Rumsfeld, J.S., Medication adherence: its importance in cardiovascular outcomes. Circulation 119:23 (2009), 3028–3035.
5. 5 Krousel-Wood, M., Holt, E., Joyce, C., et al. Differences in cardiovascular disease risk when antihypertensive medication adherence is assessed by pharmacy fill versus self-report: the Cohort Study of Medication Adherence among Older Adults (CoSMO). J Hypertens 33:2 (2015), 412–420.
6. 6 Krousel-Wood, M., Thomas, S., Muntner, P., et al. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 19:4 (2004), 357–362.
7. 7 Krousel-Wood, M.A., Muntner, P., Islam, T., et al. Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults. Med Clin North Am 93:3 (2009), 753–769.
8. 8 Wright, J.T. Jr., Williamson, J.D., Whelton, P.K., et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373:22 (2015), 2103–2116.
9. 9 Williamson, J.D., Supiano, M.A., Applegate, W.B., et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged >/=75 years: a randomized clinical trial. JAMA 315:24 (2016), 2673–2682.
10. 10 Leung, A.A., Nerenberg, K., Daskalopoulou, S.S., et al. Hypertension Canada's 2016 Canadian hypertension education program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol 32:5 (2016), 569–588.
11. 11 Conn, V.S., Ruppar, T.M., Chase, J.A., et al. Interventions to improve medication adherence in hypertensive patients: systematic review and meta-analysis. Curr Hypertens Rep, 17(12), 2015, 94.
12. 12 Cook, N.R., Cohen, J., Hebert, P.R., et al. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med 155:7 (1995), 701–709.
13. 13 Stamler, J., Stamler, R., Neaton, J.D., Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 153:5 (1993), 598–615.
14. 14 Collins, R., Peto, R., MacMahon, S., et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 335:8693 (1990), 827–838.
15. 15 Ogedegbe, G., Harrison, M., Robbins, L., et al. Reasons patients do or do not take their blood pressure medications. Ethn Dis, 14(1), 2004, 158.
16. 16 Ogedegbe, G., Harrison, M., Robbins, L., et al. Barriers and facilitators of medication adherence in hypertensive African Americans: a qualitative study. Ethn Dis 14:1 (2004), 3–12.
17. 17 Krousel-Wood, M.A., Frohlich, E.D., Hypertension and depression: coexisting barriers to medication adherence. J Clin Hypertens (Greenwich) 12:7 (2010), 481–486.
18. 18 Krousel-Wood, M., Islam, T., Muntner, P., et al. Association of depression with antihypertensive medication adherence in older adults: cross-sectional and longitudinal findings from CoSMO. Ann Behav Med 40:3 (2010), 248–257.
19. 19 Grenard, J.L., Munjas, B.A., Adams, J.L., et al. Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Intern Med 26:10 (2011), 1175–1182.
20. 20 Wang, P.S., Avorn, J., Brookhart, M.A., et al. Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives. Hypertension 46:2 (2005), 273–279.
21. 21 Wang, P.S., Bohn, R.L., Knight, E., et al. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med 17:7 (2002), 504–511.
22. 22 Egan, B.M., Lackland, D.T., Cutler, N.E., Awareness, knowledge, and attitudes of older Americans about high blood pressure: implications for health care policy, education, and research. Arch Intern Med 163:6 (2003), 681–687.
23. 23 Egan, B.M., Zhao, Y., Axon, R.N., US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 303:20 (2010), 2043–2050.
24. 24 Ogedegbe, G., Mancuso, C.A., Allegrante, J.P., Expectations of blood pressure management in hypertensive African-American patients: a qualitative study. J Natl Med Assoc 96:4 (2004), 442–449.
25. 25 Briesacher, B.A., Gurwitz, J.H., Soumerai, S.B., Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med 22:6 (2007), 864–871.
26. 26 Kronish, I.M., Diefenbach, M.A., Edmondson, D.E., et al. Key barriers to medication adherence in survivors of strokes and transient ischemic attacks. J Gen Intern Med 28:5 (2013), 675–682.
27. 27 Edmondson, D., Horowitz, C.R., Goldfinger, J.Z., et al. Concerns about medications mediate the association of posttraumatic stress disorder with adherence to medication in stroke survivors. Br J Health Psychol 18:4 (2013), 799–813.
28. 28 Iskedjian, M., Einarson, T.R., MacKeigan, L.D., et al. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin Ther 24:2 (2002), 302–316.
29. 29 Brown, C.M., Barner, J.C., Richards, K.M., et al. Patterns of complementary and alternative medicine use in African Americans. J Altern Complement Med 13:7 (2007), 751–758.
30. 30 Gohar, F., Greenfield, S.M., Beevers, D.G., et al. Self-care and adherence to medication: a survey in the hypertension outpatient clinic. BMC Complement Altern Med, 8, 2008, 4.
31. 31 Krousel-Wood, M.A., Muntner, P., Joyce, C.J., et al. Adverse effects of complementary and alternative medicine on antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults. J Am Geriatr Soc 58:1 (2010), 54–61.
32. 32 World Health Organization. Adherence to long-term therapies: Evidence for action. 2003.
33. 33 Hagiwara, N., Penner, L.A., Gonzalez, R., et al. Racial attitudes, physician-patient talk time ratio, and adherence in racially discordant medical interactions. Soc Sci Med 87 (2013), 123–131.
34. 34 Holt, E., Joyce, C., Dornelles, A., et al. Sex differences in barriers to antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults. J Am Geriatr Soc 61:4 (2013), 558–564.
35. 35 Lutfey, K., On practices of ‘good doctoring’: reconsidering the relationship between provider roles and patient adherence. Sociol Health Illn 27:4 (2005), 421–447.
36. 36 Gregoire, J.P., Moisan, J., Guibert, R., et al. Tolerability of antihypertensive drugs in a community-based setting. Clin Ther 23:5 (2001), 715–726.
37. 37 Morisky, D.E., Ang, A., Krousel-Wood, M.A., et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens 10 (2008), 348–354.
38. 38 Morisky, D.E., Green, L.W., Levine, D.M., Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24:1 (1986), 67–74.
39. 39 Holt, E.W., Muntner, P., Joyce, C., et al. Life events, coping, and antihypertensive medication adherence among older adults: the cohort study of medication adherence among older adults. Am J Epidemiol 176:Suppl 7 (2012), S64–S71.
40. 40 Fongwa, M.N., Evangelista, L.S., Hays, R.D., et al. Adherence treatment factors in hypertensive African American women. Vasc Health Risk Manag 4:1 (2008), 157–166.
41. 41 Hyre, A.D., Krousel-Wood, M.A., Muntner, P., et al. Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting. J Clin Hypertens (Greenwich) 9:3 (2007), 179–186.
42. 42 Rollnick, S., Miller, W.R., Butler, C., Motivational interviewing in health care: helping patients change behavior. 2008, Guilford Press, New York.
43. 43 Kripalani, S., Yao, X., Haynes, R.B., Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med 167:6 (2007), 540–550.
44. 44 Nau, D.P., Proportion of days covered (PDC) as a preferred method of measuring medication adherence. 2012, Pharmacy Quality Alliance, Springfield (VA).
45. 45 Choudhry, N.K., Shrank, W.H., Levin, R.L., et al. Measuring concurrent adherence to multiple related medications. Am J Manag Care 15:7 (2009), 457–464.
46. 46 Farmer, K.C., Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 21:6 (1999), 1074–1090 [discussion: 1073].
47. 47 Krousel-Wood, M., Islam, T., Webber, L.S., et al. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care 15:1 (2009), 59–66.
48. 48 Krousel-Wood, M., Joyce, C., Holt, E.W., et al. Development and evaluation of a self-report tool to predict low pharmacy refill adherence in elderly patients with uncontrolled hypertension. Pharmacotherapy 33:8 (2013), 798–811.
49. 49 Kim, M.T., Hill, M.N., Bone, L.R., et al. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Prog Cardiovasc Nurs 15:3 (2000), 90–96.
50. 50 McHorney, C.A., The Adherence Estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease. Curr Med Res Opin 25:1 (2009), 215–238.
51. 51 Cohen, J., Statistical power analysis for the behavioral sciences (revised edition). 1977, Academic Press, New York.
52. 52 Fletcher, B.R., Hartmann-Boyce, J., Hinton, L., et al. The effect of self-monitoring of blood pressure on medication adherence and lifestyle factors: a systematic review and meta-analysis. Am J Hypertens 28:10 (2015), 1209–1221.
53. 53 van Dalem, J., Krass, I., Aslani, P., Interventions promoting adherence to cardiovascular medicines. Int J Clin Pharm 34:2 (2012), 295–311.
54. 54 Viswanathan, M., Golin, C.E., Jones, C.D., et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med 157:11 (2012), 785–795.
55. 55 Conn, V.S., Ruppar, T.M., Chase, J.D., Blood pressure outcomes of medication adherence interventions: systematic review and meta-analysis. J Behav Med, 2016 [Epub ahead of print].
56. 56 Volpp, K.G., The counseling African Americans to control hypertension study and ways to enhance the next wave of behavioral interventions. Circulation 129:20 (2014), 2002–2004.
57. 57 Patel, B.V., Leslie, R.S., Thiebaud, P., et al. Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimen. Vasc Health Risk Manag 4:3 (2008), 673–681.
58. 58 Omboni, S., Gazzola, T., Carabelli, G., et al. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens 31:3 (2013), 455–467 [discussion: 467–58].
59. 59 Chernew, M.E., Shah, M.R., Wegh, A., et al. Impact of decreasing copayments on medication adherence within a disease management environment. Health Aff (Millwood) 27:1 (2008), 103–112.
60. 60 Maciejewski, M.L., Farley, J.F., Parker, J., et al. Copayment reductions generate greater medication adherence in targeted patients. Health Aff (Millwood) 29:11 (2010), 2002–2008.
61. 61 Zhang, Y., Lave, J.R., Donohue, J.M., et al. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products. Med Care 48:5 (2010), 409–417.
62. 62 Li, P., McElligott, S., Bergquist, H., et al. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia. Ann Intern Med 156:11 (2012), 776–784 w-263, w-264, w-265, w-266, w-267, w-268, w-269.
63. 63 Volpp, K., Troxel, A., Long, J., et al. A randomized controlled trial of co-payment elimination: the CHORD trial. Am J Manag Care 21:8 (2014), e455–e464.
64. 64 Cheema, E., Sutcliffe, P., Singer, D.R., The impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol 78:6 (2014), 1238–1247.
65. 65 Glynn, L.G., Murphy, A.W., Smith, S.M., et al. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev(3), 2010 CD005182.
66. 66 Morgado, M.P., Morgado, S.R., Mendes, L.C., et al. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: review and meta-analysis. Am J Health Syst Pharm 68:3 (2011), 241–253.
67. 67 Santschi, V., Chiolero, A., Colosimo, A.L., et al. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc, 3(2), 2014, e000718.
68. 68 Proia, K.K., Thota, A.B., Njie, G.J., et al. Team-based care and improved blood pressure control: a community guide systematic review. Am J Prev Med 47:1 (2014), 86–99.
69. 69 Mansoor, S.M., Krass, I., Aslani, P., Multiprofessional interventions to improve patient adherence to cardiovascular medications. J Cardiovasc Pharmacol Ther 18:1 (2013), 19–30.
70. 70 Bray, E.P., Holder, R., Mant, J., et al. Does self-monitoring reduce blood pressure? Meta-analysis with meta-regression of randomized controlled trials. Ann Med 42:5 (2010), 371–386.
71. 71 Uhlig, K., Patel, K., Ip, S., et al. Self-measured blood pressure monitoring in the management of hypertension: a systematic review and meta-analysis. Ann Intern Med 159:3 (2013), 185–194.
72. 72 Mistry, N., Keepanasseril, A., Wilczynski, N.L., et al. Technology-mediated interventions for enhancing medication adherence. J Am Med Inform Assoc 22:e1 (2015), e177–e193.
73. 73 Liu, S., Dunford, S.D., Leung, Y.W., et al. Reducing blood pressure with Internet-based interventions: a meta-analysis. Can J Cardiol 29:5 (2013), 613–621.
74. 74 Thakkar, J., Kurup, R., Laba, T.L., et al. Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis. JAMA Intern Med 176:3 (2016), 340–349.
75. 75 McLean, G., Band, R., Saunderson, K., et al. Digital interventions to promote self-management in adults with hypertension systematic review and meta-analysis. J Hypertens 34:4 (2016), 600–612.
76. 76 Morrissey, E.C., Corbett, T.K., Walsh, J.C., et al. Behavior change techniques in apps for medication adherence: a content analysis. Am J Prev Med 50:5 (2016), e143–e146.
77. 77 Nieuwlaat, R., Wilczynski, N., Navarro, T., et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev(11), 2014 CD000011.
78. 78 Krousel-Wood, M., Kegan, R., Whelton, P.K., et al. Immunity-to-change: are hidden motives underlying patient nonadherence to chronic disease medications?. Am J Med Sci 348:2 (2014), 121–128.
79. 79 Bogner, H.R., de Vries, H.F., Integration of depression and hypertension treatment: a pilot, randomized controlled trial. Ann Fam Med 6:4 (2008), 295–301.
80. 80 Chao, J., Nau, D.P., Aikens, J.E., et al. The mediating role of health beliefs in the relationship between depressive symptoms and medication adherence in persons with diabetes. Res Social Adm Pharm 1:4 (2005), 508–525.
81. 81 Schoenthaler, A., Ogedegbe, G., Allegrante, J.P., Self-efficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive African Americans. Health Educ Behav 36:1 (2009), 127–137.
82. 82 Gellad, W.F., Haas, J.S., Safran, D.G., Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study. J Gen Intern Med 22:11 (2007), 1572–1578.
83. 83 Holmes, H.M., Luo, R., Hanlon, J.T., et al. Ethnic disparities in adherence to antihypertensive medications of medicare part D beneficiaries. J Am Geriatr Soc 60:7 (2012), 1298–1303.
84. 84 Ishisaka, D.Y., Jukes, T., Romanelli, R.J., et al. Disparities in adherence to and persistence with antihypertensive regimens: an exploratory analysis from a community-based provider network. J Am Soc Hypertens 6:3 (2012), 201–209.
85. 85 Conn, V.S., Ruppar, T.M., Enriquez, M., et al. Medication adherence interventions that target subjects with adherence problems: systematic review and meta-analysis. Res Social Adm Pharm 12:2 (2016), 218–246.
86. 86 Hugtenburg, J.G., Timmers, L., Elders, P.J., et al. Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions. Patient Prefer Adherence 7 (2013), 675–682.
87. 87 Vasan, R.S., Larson, M.G., Benjamin, E.J., et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 33:7 (1999), 1948–1955.
88. 88 Senni, M., Redfield, M.M., Heart failure with preserved systolic function. A different natural history?. J Am Coll Cardiol 38:5 (2001), 1277–1282.
89. 89 Farley, T.A., Dalal, M.A., Mostashari, F., et al. Deaths preventable in the U.S. by improvements in use of clinical preventive services. Am J Prev Med 38:6 (2010), 600–609.
90. 90 Margolius, D., Bodenheimer, T., Bennett, H., et al. Health coaching to improve hypertension treatment in a low-income, minority population. Ann Fam Med 10:3 (2012), 199–205.